Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App





CerTest Showcases Latest Innovations in Diagnosis of Infectious Diseases

By LabMedica International staff writers
Posted on 12 Nov 2024

CerTest Biotec (Zaragoza, Spain) is ending the 2024 exhibition calendar with its participation in this year’s MEDICA. More...

With more than 5,300 exhibitors from almost 70 different countries, MEDICA is one of the largest medical B2B exhibitions in the world. CerTest is presenting again at MEDICA this year, highlighting the different medical diagnostic technologies it has developed to over 83,000 visitors expected at the event. At MEDICA 2024, Certest is showcasing the V-Flex system that is part of its VIASURE Complete Solution designed to achieve a better molecular diagnostic workflow. The VIASURE V-FLEX system is a new fully automated solution in molecular biology for nucleic acid extraction, purification, and PCR set-up from biological matrix and samples. The instrument has been designed with flexible configurations to meet different user needs.

Visitors to the Certest booth can also learn about the VIASURE DNA/RNA pathogen extraction kit designed to extract from various biological samples: swabs, saliva, sputum, bronchoalveolar lavages, fecal and urine samples. The kit is based on magnetic particles, which allows its automation for high throughput analysis, reducing hands-on time and improving reproducibility. The extraction kit is currently optimized for two types of magnetic separation methods: VIASURE V-Flex and KingFisher Flex. Certest is also demonstrating the VIASURE V-Smart software that allows the analysis and interpretation of the VIASURE Real-Time PCR assays. VIASURE V-Smart facilitates the conversion of the PCR raw data into test results with minimal manual intervention.

Related Links:
CerTest Biotec


Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.